Unjha Formulations submits FY2026 financial statements to BSE

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹33.77

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+5.1% vs market

Pharmaceuticals peers, median of 174sector-0.2%+5.2% vs sector

On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 5.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0-0.2+5.1-0.2+5.2

Next day

-0.3-0.3+0.1-0.7+0.5

-0.3-0.2-0.0-0.8+0.5

-1.4-3.5+2.1-2.2+0.8

-5.2-3.6-1.6-2.4-2.8

-5.3-2.8-2.5-2.3-3.0

-0.1-1.4+1.3-0.8+0.7

15d

-2.3-3.0+0.7-2.1-0.2

+0.4-4.4+4.8-5.1+5.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unjha Formulations has submitted the XML file of its Balance Sheet, Profit and Loss accounts, and Cash Flow Statement for the year ended 31 March 2026 to BSE. The Annual General Meeting was held on 14 August 2026. This submission is a routine regulatory requirement under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. No specific financial figures or performance details are disclosed in this filing notice.

Likely market impact

Routine regulatory filing with no immediate impact on stock price. Investors should review the actual financial statements for performance details.